Nuo Therapeutics, Inc.
General ticker "AURX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $75.7M (TTM average)
Nuo Therapeutics, Inc. follows the US Stock Market performance with the rate: 36.3%.
Estimated limits based on current volatility of 1.3%: low 2.15$, high 2.20$
Factors to consider:
- Total employees count: 12 as of 2006
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [0.65$, 2.08$]
- 2025-12-31 to 2026-12-31 estimated range: [0.43$, 1.43$]
Financial Metrics affecting the AURX estimates:
- Positive: with PPE of -29.0 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -3.30 <= 0.33
- Negative: negative Industry operating cash flow (median)
- Negative: negative Net income
- Positive: Investing cash flow per share per price, % of -0.23 > -0.66
- Positive: 41.86 < Shareholder equity ratio, % of 43.19 <= 63.39
Short-term AURX quotes
Long-term AURX plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.11MM | $0.61MM | $1.37MM |
| Operating Expenses | $3.43MM | $3.78MM | $3.82MM |
| Operating Income | $-3.32MM | $-3.17MM | $-2.46MM |
| Non-Operating Income | $0.15MM | $-0.00MM | $0.13MM |
| Interest Expense | $0.00MM | $0.00MM | $0.00MM |
| Income(Loss) | $-3.17MM | $-3.17MM | $-2.32MM |
| Profit(Loss)* | $-3.03MM | $-3.17MM | $-2.32MM |
| Stockholders Equity | $2.19MM | $1.04MM | $0.51MM |
| Assets | $3.05MM | $1.88MM | $1.19MM |
| Operating Cash Flow | $-3.71MM | $-3.17MM | $-2.23MM |
| Capital expenditure | $0.06MM | $0.01MM | $0.15MM |
| Investing Cash Flow | $-0.06MM | $-0.01MM | $-0.15MM |
| Financing Cash Flow | $4.46MM | $2.00MM | $1.74MM |
| Earnings Per Share** | $-0.08 | $-0.08 | $-0.05 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.